Analysis and Commentary 2/1/20 Analysis and Commentary 2/1/20 FDA's FY 21 Appropriation: What's Happening When? Read More Analysis and Commentary 1/25/20 Analysis and Commentary 1/25/20 Alliance Learns About CBER Priorities for 2020 and Beyond Read More Analysis and Commentary 1/17/20 Analysis and Commentary 1/17/20 Hill Day and Other Upcoming Alliance Advocacy Initiatives Read More Analysis and Commentary 1/10/20 Analysis and Commentary 1/10/20 FDA Is Its People Read More Analysis and Commentary 12/20/19 Analysis and Commentary 12/20/19 Success Again in 2019 ... Building Support for 2020 Read More Analysis and Commentary 12/16/19 Analysis and Commentary 12/16/19 FDA's "Appropriation Fate" Is Evaluated on a Daily Basis Read More Analysis and Commentary 12/8/19 Analysis and Commentary 12/8/19 Three Key Questions ... and the Answers Read More Analysis and Commentary 11/22/19 Analysis and Commentary 11/22/19 Time to Talk Turkey ... Once Again Read More Analysis and Commentary 11/14/19 Analysis and Commentary 11/14/19 FY 20 Appropriations: More Qs; More As Read More Analysis and Commentary 11/11/19 Analysis and Commentary 11/11/19 FY 20 Appropriations: How, When, and Why? Read More Analysis and Commentary 11/1/19 Analysis and Commentary 11/1/19 Another Perspective on the FY 20 Tea Leaves Read More Analysis and Commentary 10/25/19 Analysis and Commentary 10/25/19 Establishing Order: The Chickens and the Eggs Read More Analysis and Commentary 10/19/19 Analysis and Commentary 10/19/19 Is Another Shutdown a Real Possibility? Read More Analysis and Commentary 10/4/19 Analysis and Commentary 10/4/19 Full-Year CR: Better Than a Shutdown, But ... Read More Analysis and Commentary 9/30/19 Analysis and Commentary 9/30/19 "Wouldn't It Be Wonderful" Read More Analysis and Commentary 9/20/19 Analysis and Commentary 9/20/19 More Questions and More Answers ... Once Again Read More Analysis and Commentary 9/13/19 Analysis and Commentary 9/13/19 CR-Level Funding at Start of FY 20 Approaches Certainty Read More Analysis and Commentary 9/6/19 Analysis and Commentary 9/6/19 Much to Gain from a Smooth Appropriations Process Read More Analysis and Commentary 8/23/19 Analysis and Commentary 8/23/19 Sometimes Things Just Don't Go as Planned (or Hoped) Read More Analysis and Commentary 8/11/19 Analysis and Commentary 8/11/19 Angling for Optimism Read More Newer Posts Older Posts
Analysis and Commentary 2/1/20 Analysis and Commentary 2/1/20 FDA's FY 21 Appropriation: What's Happening When? Read More
Analysis and Commentary 1/25/20 Analysis and Commentary 1/25/20 Alliance Learns About CBER Priorities for 2020 and Beyond Read More
Analysis and Commentary 1/17/20 Analysis and Commentary 1/17/20 Hill Day and Other Upcoming Alliance Advocacy Initiatives Read More
Analysis and Commentary 12/20/19 Analysis and Commentary 12/20/19 Success Again in 2019 ... Building Support for 2020 Read More
Analysis and Commentary 12/16/19 Analysis and Commentary 12/16/19 FDA's "Appropriation Fate" Is Evaluated on a Daily Basis Read More
Analysis and Commentary 12/8/19 Analysis and Commentary 12/8/19 Three Key Questions ... and the Answers Read More
Analysis and Commentary 11/22/19 Analysis and Commentary 11/22/19 Time to Talk Turkey ... Once Again Read More
Analysis and Commentary 11/14/19 Analysis and Commentary 11/14/19 FY 20 Appropriations: More Qs; More As Read More
Analysis and Commentary 11/11/19 Analysis and Commentary 11/11/19 FY 20 Appropriations: How, When, and Why? Read More
Analysis and Commentary 11/1/19 Analysis and Commentary 11/1/19 Another Perspective on the FY 20 Tea Leaves Read More
Analysis and Commentary 10/25/19 Analysis and Commentary 10/25/19 Establishing Order: The Chickens and the Eggs Read More
Analysis and Commentary 10/19/19 Analysis and Commentary 10/19/19 Is Another Shutdown a Real Possibility? Read More
Analysis and Commentary 10/4/19 Analysis and Commentary 10/4/19 Full-Year CR: Better Than a Shutdown, But ... Read More
Analysis and Commentary 9/20/19 Analysis and Commentary 9/20/19 More Questions and More Answers ... Once Again Read More
Analysis and Commentary 9/13/19 Analysis and Commentary 9/13/19 CR-Level Funding at Start of FY 20 Approaches Certainty Read More
Analysis and Commentary 9/6/19 Analysis and Commentary 9/6/19 Much to Gain from a Smooth Appropriations Process Read More
Analysis and Commentary 8/23/19 Analysis and Commentary 8/23/19 Sometimes Things Just Don't Go as Planned (or Hoped) Read More
